---
document_datetime: 2023-09-21 18:51:45
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/rasilamlo-epar-all-authorised-presentations_en.pdf
document_name: rasilamlo-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 5.4355612
conversion_datetime: 2025-12-18 20:51:21.118162
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| EU Number       | Invented name   | Strength     | Pharmaceutical Form        | Route of Administration   | Packaging            | Package size                    |
|-----------------|-----------------|--------------|----------------------------|---------------------------|----------------------|---------------------------------|
| EU/1/11/686/001 | Rasilamlo       | 150 mg/5 mg  | Film-coated tablet         | Oral use                  | blister (PVC/PCTFE)  | 14 tablets                      |
| EU/1/11/686/002 | Rasilamlo       | 150 mg/5 mg  | Film-coated tablet         | Oral use                  | blister (PVC/PCTFE)  | 28 tablets                      |
| EU/1/11/686/003 | Rasilamlo       | 150 mg/5 mg  | Film-coated tablet         | Oral use                  | blister (PVC/PCTFE)  | 30 tablets                      |
| EU/1/11/686/004 | Rasilamlo       | 150 mg/5 mg  | Film-coated tablet         | Oral use                  | blister (PVC/PCTFE)  | 56 tablets                      |
| EU/1/11/686/005 | Rasilamlo       | 150 mg/5 mg  | Film-coated tablet         | Oral use                  | blister (PVC/PCTFE)  | 90 tablets                      |
| EU/1/11/686/006 | Rasilamlo       | 150 mg/5 mg  | Film-coated tablet         | Oral use                  | blister (PVC/PCTFE)  | 98 tablets                      |
| EU/1/11/686/007 | Rasilamlo       | 150 mg/5 mg  | Film-coated tablet         | Oral use                  | blister (PVC/PCTFE)  | 56x1 tablets                    |
| EU/1/11/686/008 | Rasilamlo       | 150 mg/5 mg  | Film-coated tablet         | Oral use                  | blister (PVC/PCTFE)  | 98 (2x49x1) tablets (multipack) |
| EU/1/11/686/009 | Rasilamlo       | 150 mg/5 mg  | Film-coated tablet         | Oral use                  | blister (PVC/PCTFE)  | 280 (20x14) tablets (multipack) |
| EU/1/11/686/010 | Rasilamlo       | 150 mg/5 mg  | Film-coated tablet         | Oral use                  | blister (PA/Alu/PVC) | 14 tablets                      |
| EU/1/11/686/011 | Rasilamlo       | 150 mg/5 mg  | Film-coated tablet         | longer Oral use           | blister (PA/Alu/PVC) | 28 tablets                      |
| EU/1/11/686/012 | Rasilamlo       | 150 mg/5 mg  | Film-coated tablet         | Oral use                  | blister (PA/Alu/PVC) | 56 tablets                      |
| EU/1/11/686/013 | Rasilamlo       | 150 mg/5 mg  | Film-coated tablet         | Oral use                  | blister (PA/Alu/PVC) | 98 (2x49) tablets (multipack)   |
| EU/1/11/686/014 | Rasilamlo       | 150 mg/5 mg  | Film-coated tablet         | Oral use                  | blister (PA/Alu/PVC) | 280 (20x14) tablets (multipack) |
| EU/1/11/686/015 | Rasilamlo       | 150 mg/10 mg | no Film-coated tablet      | Oral use                  | blister (PVC/PCTFE)  | 14 tablets                      |
| EU/1/11/686/016 | Rasilamlo       | 150 mg/10 mg | Film-coated tablet         | Oral use                  | blister (PVC/PCTFE)  | 28 tablets                      |
| EU/1/11/686/017 | Rasilamlo       | 150 mg/10 mg | Film-coated tablet         | Oral use                  | blister (PVC/PCTFE)  | 30 tablets                      |
| EU/1/11/686/018 | Rasilamlo       | 150 mg/10 mg | Film-coated tablet         | Oral use                  | blister (PVC/PCTFE)  | 56 tablets                      |
| EU/1/11/686/019 | Rasilamlo       | 150 mg/10 mg | Film-coated tablet         | Oral use                  | blister (PVC/PCTFE)  | 90 tablets                      |
| EU/1/11/686/020 | Rasilamlo       | 150 mg/10 mg | Film-coated tablet         | Oral use                  | blister (PVC/PCTFE)  | 98 tablets                      |
| EU/1/11/686/021 | Rasilamlo       | 150 mg/10 mg | Film-coated tablet         | Oral use                  | blister (PVC/PCTFE)  | 56x1 tablets                    |
| EU/1/11/686/022 | Rasilamlo       | 150 mg/10 mg | Film-coated tablet         | Oral use                  | blister (PVC/PCTFE)  | 98 (2x49x1) tablets (multipack) |
| EU/1/11/686/023 | Rasilamlo       | 150 mg/10 mg | product Film-coated tablet | Oral use                  | blister (PVC/PCTFE)  | 280 (20x14) tablets (multipack) |
| EU/1/11/686/024 | Rasilamlo       | 150 mg/10 mg | Film-coated tablet         | Oral use                  | blister (PA/Alu/PVC) | 14 tablets                      |
| EU/1/11/686/025 | Rasilamlo       | 150 mg/10 mg | Film-coated tablet         | Oral use                  | blister (PA/Alu/PVC) | 28 tablets                      |
| EU/1/11/686/026 | Rasilamlo       | 150 mg/10 mg | Film-coated tablet         | Oral use                  | blister (PA/Alu/PVC) | 56 tablets                      |
| EU/1/11/686/027 | Rasilamlo       | 150 mg/10 mg | Film-coated tablet         | Oral use                  | blister (PA/Alu/PVC) | 98 (2x49) tablets (multipack)   |
| EU/1/11/686/028 | Rasilamlo       | 150 mg/10 mg | Film-coated tablet         | Oral use                  | blister (PA/Alu/PVC) | 280 (20x14) tablets (multipack) |
| EU/1/11/686/029 | Rasilamlo       | 300 mg/5 mg  | Film-coated tablet         | Oral use                  | blister (PVC/PCTFE)  | 14 tablets                      |
| EU/1/11/686/030 | Rasilamlo       | 300 mg/5 mg  | Film-coated tablet         | Oral use                  | blister (PVC/PCTFE)  | 28 tablets                      |

Medicinal product no longer authorised 1/2

<div style=\"page-break-after: always\"></div>

| EU/1/11/686/031   | Rasilamlo   | 300 mg/5 mg   | Film-coated tablet         | Oral use        | blister (PVC/PCTFE)   | 30 tablets                      |
|-------------------|-------------|---------------|----------------------------|-----------------|-----------------------|---------------------------------|
| EU/1/11/686/032   | Rasilamlo   | 300 mg/5 mg   | Film-coated tablet         | Oral use        | blister (PVC/PCTFE)   | 56 tablets                      |
| EU/1/11/686/033   | Rasilamlo   | 300 mg/5 mg   | Film-coated tablet         | Oral use        | blister (PVC/PCTFE)   | 90 tablets                      |
| EU/1/11/686/034   | Rasilamlo   | 300 mg/5 mg   | Film-coated tablet         | Oral use        | blister (PVC/PCTFE)   | 98 tablets                      |
| EU/1/11/686/035   | Rasilamlo   | 300 mg/5 mg   | Film-coated tablet         | Oral use        | blister (PVC/PCTFE)   | 56x1 tablets                    |
| EU/1/11/686/036   | Rasilamlo   | 300 mg/5 mg   | Film-coated tablet         | Oral use        | blister (PVC/PCTFE)   | 98 (2x49x1) tablets (multipack) |
| EU/1/11/686/037   | Rasilamlo   | 300 mg/5 mg   | Film-coated tablet         | Oral use        | blister (PVC/PCTFE)   | 280 (20x14) tablets (multipack) |
| EU/1/11/686/038   | Rasilamlo   | 300 mg/5 mg   | Film-coated tablet         | Oral use        | blister (PA/Alu/PVC)  | 14 tablets                      |
| EU/1/11/686/039   | Rasilamlo   | 300 mg/5 mg   | Film-coated tablet         | Oral use        | blister (PA/Alu/PVC)  | 28 tablets                      |
| EU/1/11/686/040   | Rasilamlo   | 300 mg/5 mg   | Film-coated tablet         | Oral use        | blister (PA/Alu/PVC)  | 56 tablets                      |
| EU/1/11/686/041   | Rasilamlo   | 300 mg/5 mg   | Film-coated tablet         | Oral use        | blister (PA/Alu/PVC)  | 98 (2x49) tablets (multipack)   |
| EU/1/11/686/042   | Rasilamlo   | 300 mg/5 mg   | Film-coated tablet         | longer Oral use | blister (PA/Alu/PVC)  | 280 (20x14) tablets (multipack) |
| EU/1/11/686/043   | Rasilamlo   | 300 mg/10 mg  | Film-coated tablet         | Oral use        | blister (PVC/PCTFE)   | 14 tablets                      |
| EU/1/11/686/044   | Rasilamlo   | 300 mg/10 mg  | Film-coated tablet         | Oral use        | blister (PVC/PCTFE)   | 28 tablets                      |
| EU/1/11/686/045   | Rasilamlo   | 300 mg/10 mg  | Film-coated tablet         | Oral use        | blister (PVC/PCTFE)   | 30 tablets                      |
| EU/1/11/686/046   | Rasilamlo   | 300 mg/10 mg  | Film-coated tablet         | Oral use        | blister (PVC/PCTFE)   | 56 tablets                      |
| EU/1/11/686/047   | Rasilamlo   | 300 mg/10 mg  | no Film-coated tablet      | Oral use        | blister (PVC/PCTFE)   | 90 tablets                      |
| EU/1/11/686/048   | Rasilamlo   | 300 mg/10 mg  | Film-coated tablet         | Oral use        | blister (PVC/PCTFE)   | 98 tablets                      |
| EU/1/11/686/049   | Rasilamlo   | 300 mg/10 mg  | Film-coated tablet         | Oral use        | blister (PVC/PCTFE)   | 56x1 tablets                    |
| EU/1/11/686/050   | Rasilamlo   | 300 mg/10 mg  | Film-coated tablet         | Oral use        | blister (PVC/PCTFE)   | 98 (2x49x1) tablets (multipack) |
| EU/1/11/686/051   | Rasilamlo   | 300 mg/10 mg  | product Film-coated tablet | Oral use        | blister (PVC/PCTFE)   | 280 (20x14) tablets (multipack) |
| EU/1/11/686/052   | Rasilamlo   | 300 mg/10 mg  | Film-coated tablet         | Oral use        | blister (PA/Alu/PVC)  | 14 tablets                      |
| EU/1/11/686/053   | Rasilamlo   | 300 mg/10 mg  | Film-coated tablet         | Oral use        | blister (PA/Alu/PVC)  | 28 tablets                      |
| EU/1/11/686/054   | Rasilamlo   | 300 mg/10 mg  | Film-coated tablet         | Oral use        | blister (PA/Alu/PVC)  | 56 tablets                      |
| EU/1/11/686/055   | Rasilamlo   | 300 mg/10 mg  | Film-coated tablet         | Oral use        | blister (PA/Alu/PVC)  | 98 (2x49) tablets (multipack)   |
| EU/1/11/686/056   | Rasilamlo   | 300 mg/10 mg  | Film-coated tablet         | Oral use        | blister (PA/Alu/PVC)  | 280 (20x14) tablets (multipack) |

Medicinal product no longer authorised 2/2